A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Angeles Alvarez Secord Carol Aghajanian Bradley J. Monk |
| Publication date | October 8, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |